ResearcherZhejiang Sci-Tech UniversityNo recent work listed

Quan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2716-0747; OpenAlex author ID A5100406674. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Co-author DOI 10.3390/pharmaceutics13091428 ↗
Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. Last author DOI 10.1016/j.ejmech.2018.03.078 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dandan Luo · 1 shared paper, 2021 · strength 0.13
- Paper siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. DOI 10.3390/pharmaceutics13091428 ↗
Xiangdong Kong · 1 shared paper, 2021 · strength 0.13
- Paper siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. DOI 10.3390/pharmaceutics13091428 ↗
Yahui Ding · 1 shared paper, 2018 · strength 0.07
- Paper Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. DOI 10.1016/j.ejmech.2018.03.078 ↗
Jian Chen · 1 shared paper, 2018 · strength 0.07
- Paper Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. DOI 10.1016/j.ejmech.2018.03.078 ↗
Yue Chen · 1 shared paper, 2018 · strength 0.07
- Paper Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. DOI 10.1016/j.ejmech.2018.03.078 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.